LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
  • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    3 Reasons Why You Should Sell Shire PLC

    Shire PLC (LON:SHP) shareholders should heed the lessons of Pfizer's bid for AstraZeneca plc (LON:AZN), says Roland Head.

    Read more »

    Investing Articles

    3 Growth Shares For Your Nisa: AstraZeneca plc, Diageo plc And Unilever plc

    AstraZeneca plc (LON:AZN), Diageo plc (LON:DGE) and Unilever plc (LON:ULVR) look to be three great growth picks for your new…

    Read more »

    Investing Articles

    Should You Invest In Shire PLC Instead Of GlaxoSmithKline plc And AstraZeneca plc?

    Is Shire PLC (LON: SHP) now a better investment than GlaxoSmithKline plc (LON: GSK) and AstraZeneca plc (LON: AZN)?

    Read more »

    Investing Articles

    Is AstraZeneca plc’s Latest Director Deal A Game-Changer?

    With AstraZeneca plc (LON:AZN)'s CEO buying shares this week, is it a significant event for investors?

    Read more »

    Investing Articles

    Why Shire PLC Could Be A Winning Stock!

    Pharmaceutical company Shire PLC (LON: SHP) could be worth buying — here’s why.

    Read more »

    Investing Articles

    One Reason Why I Would Buy AstraZeneca plc Today

    Royston Wild explains why AstraZeneca plc (LON: AZN) could become a high-profile acquisition target once again.

    Read more »

    Investing Articles

    How Strong Are AstraZeneca plc’s Dividends?

    AstraZeneca plc (LON:AZN) can afford to keep handing out the cash for a couple more years or so.

    Read more »

    Investing Articles

    AstraZeneca plc And Shire PLC Bolster Takeover Defences

    Shire PLC (LON: SHP) and AstraZeneca plc (LON: AZN) are working to repel hostile buyers.

    Read more »

    Investing Articles

    One Reason Why I Wouldn’t Buy AstraZeneca plc Today

    Royston Wild explains why AstraZeneca plc (LON: AZN) is a poor growth selection.

    Read more »

    Investing Articles

    Neil Woodford’s First Buys For His New Fund

    Disclosures by RM2 International SA (LON:RM2), ReNeuron Group Plc (LON:RENE), e-Therapeutics plc (LON:ETX); speculation on AstraZeneca plc (LON:AZN) and BAE…

    Read more »

    Investing Articles

    Why Shire PLC’s Takeover Response Is Highly Unusual

    After Abbvie’s £27bn takeover offer was rejected, Shire PLC (LON: SHP) has responded in a rather unusual way...

    Read more »

    Company Comment

    Look No Further Than AstraZeneca plc For Growth And Income

    AstraZeneca plc's (LON: AZN) impressive drugs pipeline and ambitious revenue targets make it my preferred pharma stock.

    Read more »